In honor of Women in Medicine month, the Department of Pathology would like to highlight our newest women leaders. We have several women who have moved into positions of senior leadership in the department over the past several months, joining many women colleagues serving and leading in the department.
The death of singer/songwriter Jimmy Buffett brought sadness to those of us who grew up listening to his music and enjoying the beach vibe. Buffett died from a rare, but aggressive, form of skin cancer called Merkel cell carcinoma (MCC). This cancer usually appears as a rapidly growing flesh colored or reddish-blue nodule on sun-exposed skin.
Solution will enable full-service reference laboratory that is part of Michigan Medicine to leverage vast amounts of valuable data to uncover meaningful insights, identify risk signals and deliver proactive service.
Imagine for a moment that it is 1:00 am and you and your toddler just arrived in the Emergency Department at the Mott Children’s Hospital. Your child is running a high fever, is lethargic, and hasn’t been able to eat or drink. You were at the pediatrician’s office a couple days ago, but the prescribed antibiotics aren’t working.
A study from clinicians and researchers at the University of Michigan Rogel Cancer Center, U-M Department of Pathology and the Michigan Center for Translational Pathology reveals findings from over 800 clinical assays performed for kidney patients with MiTF family gene mutations.
Congratulations to Dr. Jeffrey B. Hodgin, MD, PhD who is among the team awarded the 2023 Global Team Science Award (GTSA) given by the Lupus Research Alliance (LRA). The GTSA is given to a team of multidisciplinary researcher experts who are identifying drivers of lupus nephritis in children with the goal of improving its diagnosis and treatment.
University of Michigan Health has been recognized as the top hospital in Michigan, according to U.S. News and World Report’s Best Hospitals Rankings for 2023-24.
It is with great pleasure that we introduce Dr. Annette Kim, Division Director for Molecular and Genomic Pathology and Clinical Professor of Pathology, effective July 1, 2023. Dr. Kim joins us from Brigham and Women’s Hospital (BWH) and Harvard Medical School.
After 12 years of service as the MLabs Medical Director, Jeffrey Myers, M.D., will be focusing on his role as the Vice Chair for Clinical Affairs and Quality in the Department of Pathology and ushering in his MLabs successor, the current MLabs Associate Medical Director, Julia Dahl, M.D.
Dr. Arul Chinnaiyan, S. P. Hicks Endowed Professor of Pathology and Professor of Urology at Michigan Medicine Department of Pathology and Director of the Michigan Center for Translational Pathology, was recently recognized for his outstanding achievements by the American Association of Cancer Research. He was presented with the AACR James S. Ewing-Thelma B. Dunn Award for Outstanding Achievement in Pathology in Cancer Research award at the 2023 AACR Annual Meeting.